UPSHER-SMITH LABORATORIES
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1919-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.upsher-smith.com/
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
- First Posted Date
- 2021-02-10
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 132
- Registration Number
- NCT04748601
- Locations
- ๐บ๐ธ
Upsher-Smith Clinical Trial Site #5, Birmingham, Alabama, United States
๐บ๐ธUpsher-Smith Clinical Trial Site #15, La Jolla, California, United States
๐บ๐ธUpsher-Smith Clinical Trials Site #3, Aurora, Colorado, United States
Vogelxo(R) ABPM Study in Hypogandal Men
- First Posted Date
- 2020-09-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 122
- Registration Number
- NCT04558567
- Locations
- ๐บ๐ธ
Upsher-Smith Clinical Trial Site #1, Miami, Florida, United States
๐บ๐ธUpsher-Smith Clinical Trials Site #8, San Antonio, Texas, United States
๐บ๐ธUpsher-Smith Clinical Trial Site #2, Anaheim, California, United States
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2021-03-30
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 107
- Registration Number
- NCT02856802
- Locations
- ๐บ๐ธ
Site 33, Mount Pleasant, South Carolina, United States
๐บ๐ธSite 28, West Jordan, Utah, United States
๐บ๐ธSite 29, Rochester, New York, United States
Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
- First Posted Date
- 2010-08-30
- Last Posted Date
- 2015-02-23
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 210
- Registration Number
- NCT01191086
Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 249
- Registration Number
- NCT01142193
Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms
Phase 3
Completed
- Conditions
- First Posted Date
- 2008-08-01
- Last Posted Date
- 2008-09-26
- Lead Sponsor
- Upsher-Smith Laboratories
- Target Recruit Count
- 495
- Registration Number
- NCT00727129
ยฉ Copyright 2024. All Rights Reserved by MedPath